Varex Imaging Corporation announced its Q3 fiscal year 2021 results with revenues of $211 million, a 23% increase year-over-year, driven by demand in both the Medical and Industrial segments. GAAP net earnings were $0.29 per diluted share and non-GAAP net earnings were $0.40 per diluted share. Cash and cash equivalents improved $17 million sequentially to $128 million.
Revenues reached $211 million, driven by demand in both the Medical and Industrial segments.
Revenues increased 4% sequentially from the second quarter of fiscal year 2021 due mainly to sales gains in the Medical segment.
Revenues increased 23% year-over-year from the same quarter of the prior year driven by strength in both the Medical and Industrial segments.
Cash and cash equivalents improved $17 million sequentially to $128 million at the end of the third quarter.
The following guidance is provided for the fourth quarter of fiscal year 2021: Revenues are expected to be between $205 million and $225 million and Non-GAAP net earnings per diluted share is expected to be between $0.25 and $0.40.
Visualization of income flow from segment revenue to net income